Tag: FDA Approved Generic
Cipla USA Launches Pomalidomide Capsules, Generic Version of Pomalyst®, in All Strengths
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., announced the commercial launch of Pomalidomide Capsules in the United States. The generic equivalent of Bristol Myers Squibb's Pomalyst® is...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
Glenmark Launches Generic Vimpat®️ Injection in the US to Expand Injectable Portfolio
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of its Lacosamide Injection USP, 200mg/mL,20mg/mL, 10mg/mL available in Single-Dose Vials, as detailed in the official...